A
Description
Pharmaceutical fine chemicals CDMO with 40+ years of history, operating from Origgio (Italy), France and UK. 100% pharma-focused on custom synthesis of APIs, intermediates and building blocks. FDA/cGMP approved. Acquired by PI HealthSciences in 2023.